Shi W and Gould MN |
Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol. |
2002 |
Carcinogenesis |
pmid:11756234
|
Wei X et al. |
Perillyl alcohol inhibits TCR-mediated [Ca(2+)](i) signaling, alters cell shape and motility, and induces apoptosis in T lymphocytes. |
2000 |
Cell. Immunol. |
pmid:10805968
|
Chaudhary SC et al. |
Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. |
2009 |
Chem. Biol. Interact. |
pmid:19161993
|
Miyazawa M et al. |
Sex differences in the metabolism of (+)- and (-)-limonene enantiomers to carveol and perillyl alcohol derivatives by cytochrome p450 enzymes in rat liver microsomes. |
2002 |
Chem. Res. Toxicol. |
pmid:11800592
|
Seifert A et al. |
An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1. |
2011 |
Chembiochem |
pmid:21591046
|
Gómez-Contreras PC et al. |
In vitro induction of apoptosis in U937 cells by perillyl alcohol with sensitization by pentoxifylline: increased BCL-2 and BAX protein expression. |
2006 |
Chemotherapy |
pmid:17008791
|
Clark SS et al. |
Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion. |
2003 |
Clin. Cancer Res. |
pmid:14555523
|
Stearns V et al. |
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. |
2004 |
Clin. Cancer Res. |
pmid:15569989
|
Ripple GH et al. |
Phase I clinical trial of perillyl alcohol administered daily. |
1998 |
Clin. Cancer Res. |
pmid:9607573
|
Hudes GR et al. |
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. |
2000 |
Clin. Cancer Res. |
pmid:10955786
|
Ripple GH et al. |
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. |
2000 |
Clin. Cancer Res. |
pmid:10690515
|
Sarkar S et al. |
Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus. |
2014 |
Curr. Mol. Med. |
pmid:24236457
|
Prado R et al. |
Nonmelanoma skin cancer chemoprevention. |
2011 |
Dermatol Surg |
pmid:21895847
|
Phillips LR et al. |
Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog. |
1995 |
Drug Metab. Dispos. |
pmid:7587953
|
Miyazawa M et al. |
Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. |
2002 |
Drug Metab. Dispos. |
pmid:11950794
|
Lefranc F et al. |
4-Bromo-2-(piperidin-1-yl)thiazol-5-yl-phenyl methanone (12b) inhibits Na+/K(+)-ATPase and Ras oncogene activity in cancer cells. |
2013 |
Eur J Med Chem |
pmid:23474907
|
Russell J and Ling CC |
Studies with cytotoxic agents suggest that apoptosis is not a major determinant of clonogenic death in neuroblastoma cells. |
2003 |
Eur. J. Cancer |
pmid:14522384
|
Kennedy S et al. |
Effect of antiproliferative agents on vascular function in normal and in vitro balloon-injured porcine coronary arteries. |
2003 |
Eur. J. Pharmacol. |
pmid:14637181
|
Sundin T et al. |
eIF4E-Overexpression imparts perillyl alcohol and rapamycin-mediated regulation of telomerase reverse transcriptase. |
2013 |
Exp. Cell Res. |
pmid:23747720
|
Lantry LE et al. |
Chemopreventive efficacy of promising farnesyltransferase inhibitors. |
2000 |
Exp. Lung Res. |
pmid:11195470
|